IRIDEX ROE 2010-2023 | IRIX
Current and historical return on equity (ROE) values for IRIDEX (IRIX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| IRIDEX ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2023-12-31 |
$-0.01B |
$0.01B |
-78.43% |
| 2023-09-30 |
$-0.01B |
$0.01B |
-55.17% |
| 2023-06-30 |
$-0.01B |
$0.01B |
-50.00% |
| 2023-03-31 |
$-0.01B |
$0.02B |
-40.00% |
| 2022-12-31 |
$-0.01B |
$0.02B |
-37.33% |
| 2022-09-30 |
$-0.01B |
$0.02B |
-39.51% |
| 2022-06-30 |
$-0.01B |
$0.02B |
-36.36% |
| 2022-03-31 |
$-0.01B |
$0.02B |
-20.83% |
| 2021-12-31 |
$-0.01B |
$0.02B |
-19.80% |
| 2021-09-30 |
$-0.00B |
$0.03B |
-12.63% |
| 2021-06-30 |
$-0.00B |
$0.03B |
-13.79% |
| 2021-03-31 |
$-0.01B |
$0.03B |
-35.44% |
| 2020-12-31 |
$-0.01B |
$0.02B |
-37.84% |
| 2020-09-30 |
$-0.01B |
$0.02B |
-45.00% |
| 2020-06-30 |
$-0.01B |
$0.02B |
-41.38% |
| 2020-03-31 |
$-0.01B |
$0.02B |
-34.04% |
| 2019-12-31 |
$-0.01B |
$0.02B |
-36.00% |
| 2019-09-30 |
$-0.01B |
$0.02B |
-37.38% |
| 2019-06-30 |
$-0.01B |
$0.03B |
-37.93% |
| 2019-03-31 |
$-0.01B |
$0.03B |
-42.11% |
| 2018-12-31 |
$-0.01B |
$0.03B |
-45.61% |
| 2018-09-30 |
$-0.02B |
$0.03B |
-52.17% |
| 2018-06-30 |
$-0.02B |
$0.02B |
-51.28% |
| 2018-03-31 |
$-0.02B |
$0.03B |
-45.80% |
| 2017-12-31 |
$-0.01B |
$0.03B |
-36.11% |
| 2017-09-30 |
$-0.02B |
$0.04B |
-50.00% |
| 2017-06-30 |
$-0.02B |
$0.04B |
-44.74% |
| 2017-03-31 |
$-0.01B |
$0.04B |
-37.58% |
| 2016-12-31 |
$-0.01B |
$0.04B |
-33.57% |
| 2016-09-30 |
$-0.00B |
$0.04B |
-2.90% |
| 2016-06-30 |
$0.00B |
$0.04B |
0.00% |
| 2016-03-31 |
$-0.00B |
$0.03B |
-2.99% |
| 2015-12-31 |
$-0.00B |
$0.03B |
-2.99% |
| 2015-09-30 |
$0.01B |
$0.03B |
23.88% |
| 2015-06-30 |
$0.01B |
$0.03B |
25.20% |
| 2015-03-31 |
$0.01B |
$0.03B |
30.00% |
| 2014-12-31 |
$0.01B |
$0.03B |
31.86% |
| 2014-09-30 |
$0.00B |
$0.03B |
0.00% |
| 2014-06-30 |
$0.00B |
$0.03B |
3.85% |
| 2014-03-31 |
$0.00B |
$0.03B |
3.92% |
| 2013-12-31 |
$0.00B |
$0.03B |
8.16% |
| 2013-09-30 |
$0.00B |
$0.03B |
8.51% |
| 2013-06-30 |
$0.00B |
$0.02B |
0.00% |
| 2013-03-31 |
$0.00B |
$0.02B |
0.00% |
| 2012-12-31 |
$0.00B |
$0.02B |
4.21% |
| 2012-09-30 |
$0.00B |
$0.02B |
8.42% |
| 2012-06-30 |
$0.00B |
$0.03B |
12.90% |
| 2012-03-31 |
$0.00B |
$0.02B |
17.98% |
| 2011-12-31 |
$0.00B |
$0.02B |
14.12% |
| 2011-09-30 |
$0.00B |
$0.02B |
14.63% |
| 2011-06-30 |
$0.00B |
$0.02B |
20.51% |
| 2011-03-31 |
$0.00B |
$0.02B |
21.62% |
| 2010-12-31 |
$0.00B |
$0.02B |
17.14% |
| 2010-09-30 |
$0.00B |
$0.02B |
18.18% |
| 2010-06-30 |
$0.00B |
$0.02B |
19.35% |
| 2010-03-31 |
$0.00B |
$0.02B |
20.34% |
| 2009-12-31 |
$0.00B |
$0.02B |
21.82% |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Laser Systems and Components |
$0.048B |
$0.052B |
|
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.
|
